Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates
Authors:
- 12 September 2013
- journal article
- Published by Springer Nature in Lasers in Medical Science
- Vol. 29 (3) , 957-963
Abstract
Thulium laser resection of the prostate-tangerine technique (TmLRP-TT) dissects whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. The present study aimed to evaluate the safety and efficacy of TmLRP-TT for older symptomatic benign prostatic hyperplasia patients with large prostates during 18 months of follow-up. A prospective analysis of 95 consecutive patients with large prostates (>80 ml) who underwent surgical treatment using TmLRP-TT was carried out. All patients were evaluated preoperatively and at 1, 6, 12, and 18 months postoperatively by the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max), postvoid residual urine volume (PVR), International Index of Erectile Function 5 (IIEF-5), urine analysis, and urine culture. Perioperative complications were recorded and graded by the modified Clavien classification system (CCS). Mean preoperative prostate volume was 106.81 ± 24.79 ml. TmLRP-TT was successfully completed in all patients. The mean operative duration, catheterization time, and hospital stay were 95.36 ± 27.06 min, 2.25 ± 0.9 days, and 5.39 ± 1.18 days, respectively. The decrease in mean hemoglobin level was 1.23 ± 0.72 g/dl, and that in mean serum sodium level was 0.71 ± 2.56 mmol/l. Within the observation period of 18 months, the patients showed an improvement in IPSS (20.01 ± 7.08 vs. 4.96 ± 3.68), QoL (4.10 ± 1.16 vs. 1.23 ± 1.30), Q max (8.14 ± 3.81 ml/s vs. 18.33 ± 2.56 ml/s) and PVR (102.70 ± 70.64 ml vs. 20.28 ± 30.02 ml), compared with baseline values (P < 0.001). IIEF-5 remained stable. Minor complications occurred in 10 (10.52 %) of 95 patients (Clavien grade 1, 9.47 % and grade 2, 1.05 %). There were no severe complications requiring reintervention (Clavien grade 3, 0 % and grade 4, 0 %). TmLRP-TT is a safe and effective surgical endoscopic technique associated with a low complication rate in large prostates as assessed during an 18-month follow-up period. It is a promising technology, which may be considered as one of the alternatives to open simple prostatectomy (OP) for large prostates in the future.Keywords
This publication has 31 references indexed in Scilit:
- EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic ObstructionEuropean Urology, 2013
- Results from an international multicentre double‐blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostateBJU International, 2011
- 70 vs 120 W thulium:yttrium‐aluminium‐garnet 2 µm continuous‐wave laser for the treatment of benign prostatic hyperplasia: a systematic ex‐vivo evaluationBJU International, 2010
- The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostateWorld Journal of Urology, 2010
- Thulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective TrialEuropean Urology, 2008
- Complications and Early Postoperative Outcome After Open Prostatectomy in Patients With Benign Prostatic Enlargement: Results of a Prospective Multicenter StudyJournal of Urology, 2007
- Holmium Laser Enucleation of the Prostate Versus Open Prostatectomy for Prostates >70g: 24-Month Follow-upEuropean Urology, 2006
- First Clinical Experience with New Transurethral Bipolar Prostate Electrosurgery Resection System: Controlled Tissue Ablation (Coblation Technology ® )Journal of Endourology, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Holmium Laser Enucleation for Prostatic Adenoma: Analysis of Learning Curve Over the Course of 70 Consecutive CasesJournal of Urology, 2003